Pharmaceutical firm Rubicon Research has launched its IPO, which will remain open for three days until October 13, 2025. The company aims to raise funds for debt repayment and expansion. Key Details: Total Size: ₹1,377.5 crore Day 1 Subscription: 23% (38.24 lakh shares bid out of 1.64 crore) Non-Institutional Investors: 0.25 times subscribed Retail Investors: 0.90 times subscribed Anchor Investors: ₹619 crore raised (1.27 crore shares priced at ₹485 each) Price & Listing: Price Band: ₹461–485 per share Grey Market Premium: ₹80 (shares expected to list at ₹583) Allotment Date: October 14, 2025 Listing Date: October 16, 2025 on BSE and NSE Use of Funds: ₹310 crore for debt repayment with the remainder allocated for business growth and acquisitions.
